153 related articles for article (PubMed ID: 24259349)
1. HOXA11 hypermethylation is associated with progression of non-small cell lung cancer.
Hwang JA; Lee BB; Kim Y; Park SE; Heo K; Hong SH; Kim YH; Han J; Shim YM; Lee YS; Kim DH
Oncotarget; 2013 Dec; 4(12):2317-25. PubMed ID: 24259349
[TBL] [Abstract][Full Text] [Related]
2. HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer.
Hwang JA; Lee BB; Kim Y; Hong SH; Kim YH; Han J; Shim YM; Yoon CY; Lee YS; Kim DH
Mol Carcinog; 2015 Jun; 54 Suppl 1():E72-80. PubMed ID: 24817037
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
Hwang JA; Kim Y; Hong SH; Lee J; Cho YG; Han JY; Kim YH; Han J; Shim YM; Lee YS; Kim DH
PLoS One; 2013; 8(11):e79634. PubMed ID: 24265783
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.
Li Q; Chen C; Ren X; Sun W
Oncotarget; 2017 May; 8(20):33100-33109. PubMed ID: 28380439
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
7. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
8. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
Liu X; Zhang X; Zhan Q; Brock MV; Herman JG; Guo M
Cancer Biol Ther; 2012 Oct; 13(12):1152-7. PubMed ID: 22892849
[TBL] [Abstract][Full Text] [Related]
9. Identification of HERC5 and its potential role in NSCLC progression.
Wrage M; Hagmann W; Kemming D; Uzunoglu FG; Riethdorf S; Effenberger K; Westphal M; Lamszus K; Kim SZ; Becker N; Izbicki JR; Sandoval J; Esteller M; Pantel K; Risch A; Wikman H
Int J Cancer; 2015 May; 136(10):2264-72. PubMed ID: 25353388
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
11. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.
Yu W; Peng W; Jiang H; Sha H; Li J
Tumour Biol; 2017 Oct; 39(10):1010428317721440. PubMed ID: 29034803
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.
Heller G; Weinzierl M; Noll C; Babinsky V; Ziegler B; Altenberger C; Minichsdorfer C; Lang G; Döme B; End-Pfützenreuter A; Arns BM; Grin Y; Klepetko W; Zielinski CC; Zöchbauer-Müller S
Clin Cancer Res; 2012 Mar; 18(6):1619-29. PubMed ID: 22282464
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
[TBL] [Abstract][Full Text] [Related]
18. [The Relationship of Clinicopathology of p16 in Non-small Cell Lung Cancer and 5-nitrogen impurity-2'-deoxycytidine-nitrogen Impurity on the Influence of p16 Expression in Lung Cancer A549 Cells].
Hua CS; Ma DC; Chen H; Zhang CD; Wang WS; Ding X; Zhao J; Wu F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):404-407. PubMed ID: 30014643
[TBL] [Abstract][Full Text] [Related]
19. Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer.
Tennis MA; Vanscoyk MM; Wilson LA; Kelley N; Winn RA
PLoS One; 2012; 7(3):e32921. PubMed ID: 22403725
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes and functional study of HOXA11 in human gastric cancer.
Cui Y; Gao D; Linghu E; Zhan Q; Chen R; Brock MV; Herman JG; Guo M
Epigenomics; 2015; 7(2):201-13. PubMed ID: 25590359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
